scholarly journals Total parenteral nutrition in infants and children after abdominal surgery using a “breast milk adapted” solution of amino acids and hypertonic glucose solutions

1979 ◽  
Vol 13 (1) ◽  
pp. 81-81
Author(s):  
W Endres ◽  
I Lewandowski ◽  
J Schaub ◽  
F Höpner ◽  
F Jekat ◽  
...  
1982 ◽  
Vol 36 (05) ◽  
pp. 3-11
Author(s):  
W. Endres ◽  
I. Lewandowski ◽  
F. Höpner ◽  
F. Jekat ◽  
M. Schreiber ◽  
...  

PEDIATRICS ◽  
1996 ◽  
Vol 97 (4) ◽  
pp. 443-448
Author(s):  
Alan N. Langnas ◽  
B. W. Shaw ◽  
Dean L. Antonson ◽  
Stuart S. Kaufman ◽  
David R. Mack ◽  
...  

Objective. This report discusses the preliminary experience with intestinal transplantation in children at the University of Nebraska Medical Center. Patients. During the past 4 years, 16 intestinal transplants have been performed in infants and children. Thirteen have been combined liver and bowel transplants, and the remainder were isolated intestinal transplants. Nearly half of the patients were younger than 1 year of age at the time of surgery, and the vast majority were younger than 5 years of age. All but one had short bowel syndrome. Results. The 1-year actuarial patient and graft survival rates for recipients of liver and small bowel transplants were 76% and 61%, respectively. Eight of 13 patients who received liver and small bowel transplants remain alive at the time of this writing, with a mean length of follow-up of 263 (range, 7 to 1223) days. Six patients are currently free of total parenteral nutrition. All three patients receiving isolated intestinal transplants are alive and free of parenteral nutrition. The mean length of follow-up is 384 (range, 330 to 450) days. Major complications have included severe infections and rejection. Lymphoproliferative disease, graft-versus-host disease, and chylous ascites have not been major problems. Conclusions. Although intestinal transplantation is in its infancy, these preliminary results suggest combined liver and bowel transplants and isolated intestinal transplantation may be viable options for some patients with intestinal failure caused by short bowel syndrome or other gastrointestinal disease in whom long-term total parenteral nutrition is not an attractive option.


PEDIATRICS ◽  
1987 ◽  
Vol 79 (4) ◽  
pp. 654-655
Author(s):  
WILLIAM F. WALSH

The article "Evaluation of a Pediatric Multiple Vitamin Preparation For Total Parenteral Nutrition in Infants and Children" by Moore et al (Pediatrics 1986; 77:530-538) confused me. The study of vitamin levels is crucial to making recommendations, but why would the authors choose to give all premature infants 65% of the recommended dose for infants and children, when the package insert clearly states, "Infants less than 1 kg: the daily dose should not exceed 30% of the contents. Do not exceed this daily dose"?


1983 ◽  
Vol 2 ◽  
pp. 23
Author(s):  
E. Goroatiza ◽  
D. Feldmann ◽  
J.P. Dommergue ◽  
N. Lambert-Zechovsky ◽  
P. Danel ◽  
...  

1981 ◽  
Vol 19 (15) ◽  
pp. 57-59

Perifusin (BDH) is a solution of L-amino-acids and electrolytes which contains 5g nitrogen per litre, but no other source of energy. It is intended for the intravenous nutrition of well nourished patients through a peripheral vein, for the first few days after abdominal surgery or trauma while they cannot eat. The manufacturer claims that this form of nutrition speeds postoperative recovery and reduces complications. Perifusin thus differs in purpose, composition and route of administration from the more concentrated amino-acid solutions intended for use in total parenteral nutrition.1


Sign in / Sign up

Export Citation Format

Share Document